Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab + AVD vs BEACOPP-like in Advanced Classical Hodgkin Lymphoma
NCT07234487Phase 2Recruiting
- Sponsor
- First Saint Petersburg State Medical University
- Start
- Oct 2024
- Primary completion
- Oct 2029
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in classical Hodgkin lymphoma (cHL), sponsored by First Saint Petersburg State Medical University. Started Oct 2024; status: recruiting.
02
Drugs
03
Conditions
classical Hodgkin lymphoma (cHL)
Beyond the preview
Go deeper on NCT07234487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07234487.